With a market cap of $145.7 billion, Pfizer Inc. (PFE) is a global, research-driven biopharmaceutical company, specializing ...

Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

Ursula von der Leyen faces the biggest test of her European Commission leadership as MEPs gather to vote on a motion of ...

Pfizer Inc. closed 18.77% short of its 52-week high of $31.54, which the company achieved on July 30th.

Bristol Myers Squibb is undervalued despite challenges. Learn how BMY stock's strong pipeline, cash flow, and growth ...

At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

Changing market conditions and consumer tastes and preferences have weighed on these businesses. Investors can learn a lot ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...